logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Muscle Relaxant class drugs

    FiltersReset Filters
    11 results

    • carisoprodol

      (Carisoprodol)
      Chartwell RX, LLC
      Usage: Carisoprodol Tablets, USP are indicated for short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults, typically for durations of up to two or three weeks. Prolonged use is not recommended due to insufficient evidence of effectiveness.

    • carisoprodol

      (carisoprodol)
      Wallace Pharmaceuticals Inc.
      Usage: Carisoprodol tablets are indicated for relieving discomfort from acute, painful musculoskeletal conditions in adults. They are recommended for short-term use only (up to two to three weeks) due to insufficient evidence for prolonged effectiveness and the typically short duration of such conditions.

    • cyclobenzaprine

      (cyclobenzaprine)
      Macleods Pharmaceuticals Limited
      Usage: Cyclobenzaprine hydrochloride extended-release capsules are indicated for short-term relief of muscle spasms associated with acute, painful musculoskeletal conditions, as an adjunct to rest and physical therapy. They are not effective for spasticity due to cerebral or spinal cord diseases or in children with cerebral palsy.

    • cyclobenzaprine hydrochloride

      (cyclobenzaprine hydrochloride)
      Advagen Pharma Limited
      Usage: Cyclobenzaprine hydrochloride tablets are indicated for short-term relief of muscle spasms associated with acute, painful musculoskeletal conditions, used alongside rest and physical therapy. It is not effective for spasticity related to cerebral or spinal cord diseases or in children with cerebral palsy. Usage is limited to 2-3 weeks.

    • cyclobenzaprine hydrochloride

      (Cyclobenzaprine Hydrochloride)
      NORTHSTAR RX LLC
      Usage: Cyclobenzaprine hydrochloride tablets are indicated as an adjunct to rest and physical therapy for short-term relief of muscle spasms and associated symptoms in acute, painful musculoskeletal conditions. It is not effective for spasticity related to cerebral or spinal cord diseases or in children with cerebral palsy.

    • metaxalone

      (Metaxalone)
      Actavis Pharma, Inc.
      Usage: Metaxalone tablets are indicated for relieving discomfort associated with acute, painful musculoskeletal conditions in adults and pediatric patients aged 13 years and older, in conjunction with rest, physical therapy, and other supportive measures.

    • methocarbamol

      (Methocarbamol Tablets)
      Granules India Ltd
      Usage: Methocarbamol tablets are indicated as an adjunct to rest and physical therapy for relieving discomfort associated with acute, painful musculoskeletal conditions. Its exact mode of action is unclear but may involve sedative properties; it does not directly relax skeletal muscles.

    • methocarbamol

      (Methocarbamol)
      Solco Healthcare LLC
      Usage: Methocarbamol tablets are indicated as an adjunct treatment for relieving discomfort associated with acute, painful musculoskeletal conditions, alongside rest and physical therapy. Its exact mode of action is unclear but may involve sedative effects rather than direct muscle relaxation.

    • methocarbamol tablets, usp, 500 mg

      (Methocarbamol)
      Marlex Pharmaceuticals, Inc.
      Usage: Methocarbamol Tablets, USP are indicated as an adjunct treatment for relieving discomfort associated with acute, painful musculoskeletal conditions, alongside rest and physical therapy. Its precise mode of action is unclear, but it may involve sedative properties rather than direct muscle relaxation.

    • norgesic forte

      (Orphenadrine Citrate, Aspirin and Caffeine)
      Poly Pharmaceuticals, Inc.
      Usage: Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain from acute musculoskeletal disorders and as an adjunct to rest and physical therapy for discomfort associated with these conditions. The action of orphenadrine may relate to its analgesic properties.